Google DeepMind’s Ambitious Vision for Drug Discovery Faces Scrutiny
At Google I/O, Demis Hassabis articulated a vision for AI in drug discovery that promises to tackle all diseases. Critics highlight the need for nuanced understanding amid the hype.
More from this archive
KPMG Integrates Anthropic’s AI in Major Digital Transformation Initiative
KPMG is embedding Anthropic's AI technology, Claude, into its Digital Gateway platform to improve client services in tax…
Nvidia Surpasses Earnings Expectations with $1.87 EPS in 1Q
Nvidia's fiscal 1Q earnings report reveals an EPS of $1.87, surpassing estimates. The company forecasts $91 billion in…
OpenAI Poised for IPO, Surpassing Anthropic in Market Race
OpenAI's decision to file for an IPO is reshaping market predictions, giving it a strong lead over Anthropic.…
Google DeepMind’s CEO Predicts Approaching Singularity with AI Progress
Demis Hassabis of Google DeepMind suggests that powerful AI agents are heralding the singularity, predicting artificial general intelligence…
The archive
sorted by latest
India’s Strategic Shift to Sovereign AI Cloud Set to Transform Digital Landscape
GPUBeat Desk · 2 min
Anthropic Acquires Stainless to Boost Agentic AI Competitiveness
GPUBeat Desk · 2 min
NVIDIA Reports Record Revenue as AI Infrastructure Expansion Accelerates
GPUBeat Desk · 2 min
OpenAI Claims AI Model Solved Historic Math Conjecture
GPUBeat Desk · 2 min
Nvidia’s Earnings Report: A Bellwether for AI Growth?
GPUBeat Desk · 2 min